Found 2029 results for "cancer"
The intersection of COVID-19 vaccination and cancer treatment has generated intense interest among oncologists and patients alike. If mRNA vaccines genuinely…
Most cancer immunotherapies work for only a fraction of patients, leaving the majority without effective options. A new approach delivering three engineered…
Childhood liver cancer has historically carried a grim prognosis once standard therapies fail, making any complete response in refractory disease a meaningful…
For the roughly 2–4% of non-small-cell lung cancer patients whose tumors carry HER2 mutations, treatment options have historically lagged far behind the…
For oncology patients on immune checkpoint inhibitors, even marginal survival advantages matter enormously — which is why a large nationwide analysis…
Wildland firefighters already face elevated cancer rates — a finding now reinforced by growing evidence that the smoke they inhale contains a far more complex…
Understanding how a stomach-colonizing bacterium assembles one of its most essential survival tools could reshape how clinicians approach antibiotic-resistant…
Understanding why the same genetic mutation causes cancer in some tissues but not others is one of oncology's most vexing puzzles — and cracking it could…
Pancreatic ductal adenocarcinoma remains one of oncology's most intractable problems, with five-year survival rates stubbornly below 15%. A core reason is its…
Every mRNA vaccine or therapy ever approved — from COVID-19 shots to personalized cancer treatments — depends on a single bacterial enzyme discovered decades…
The convergence of mRNA vaccine technology and cancer immunoprevention has long been a theoretical goal — this study from PNAS moves that goal meaningfully…
The debate over ultra-processed foods isn't just about what's in them — it's about whether the science measuring their harm is reliable enough to drive…
For patients facing one of the most surgically demanding abdominal cancers, a reliable blood-based monitoring tool would be transformative. Pseudomyxoma…
Immunotherapy for lung cancer hinges on unleashing T cells against tumors — but what if the tumor's structural cells are quietly disarming those T cells…
Triple-negative breast cancer remains one of oncology's most intractable challenges precisely because it resists immunotherapy — and understanding why is a…
Among the most treatment-resistant cancers, glioblastoma has long defeated immunotherapy by maintaining an aggressively immunosuppressive microenvironment. A…
One of the most stubborn obstacles in brain cancer research is not the biology itself but the tools used to study it. Standard lab models have long failed to…
Bone metastases in medullary thyroid cancer carry a grim prognosis — roughly half of patients do not survive five years after diagnosis — yet the biological…
Annual lung cancer screening saves lives — but only if people actually return for it each year. Despite a decade of U.S. Preventive Services Task Force…
Understanding why androgen-pathway drugs eventually fail in metastatic prostate cancer is one of oncology's most pressing puzzles. A large-scale genomic…